Picobenzide

This classification denotes an antipsychotic agent with the molecular formula C15H16N2O, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier C46317G8F0, chemically known as 3,5-dimethyl-n-pyridin-4-ylmethyl-benzamide but generally known as picobenzide, which bears US NIH Compound Identifier 40146. European Medicines Agency schedules Picobenzide in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB09814MIG. The term PICOBENZIDE is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 34, No. 10 1980, List 20). PICOBENZIDE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule picobenzide under HS 29333999 and SITC 51574. As of Q4 2014, PICOBENZIDE remains the US FDA Preferred Term for this commodity. Picobenzide bears US NLM identifiers UMLS ID C0137024 and NCI Concept Code C76443. SMILES: O=C(NCC1CCNCC1)C1CC(CC(C1)C)C.